adept antibody



February 18, 2019

  • Share
  • Drug delivery using ADEPT antibody is under quick development and this approach has been tested in the clinic as a treatment for advanced colorectal carcinoma. One advantage of ADEPT is that small cytotoxic agents produced within a tumor site by the enzyme-mediated prodrug conversion has better tumor penetration than a large antibody molecule.

    Cancer Research

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.